Overview
EQ market data
Price History
EQ price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.39 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.92 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -19.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.76 – $3.54 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $127.4M · P/B 3.30 · P/S 3.10.
Company News
Equillium shares are trading higher after the company reported better-than-expected Q2 EPS results.Benzinga · Aug 14, 2026, 6:40 PM
Equillium Q2 EPS $(0.04) Beats $(0.05) EstimateBenzinga · Aug 13, 2026, 8:30 PM
8-K filing — Equillium, Inc. (EQ)SEC EDGAR · Aug 13, 2026, 8:10 PM
Piper Sandler Initiates Coverage On Equillium with Overweight Rating, Announces Price Target of $20Benzinga · Jul 13, 2026, 9:38 AM
Roth Capital Reiterates Buy on Equillium, Maintains $12 Price TargetBenzinga · Jun 2, 2026, 5:48 PM
Leerink Partners Upgrades Equillium to Outperform, Raises Price Target to $6Benzinga · May 28, 2026, 5:36 PM